Taiwan FDA registration 2bfc8682e663b562aec76ead466b2575
The Binding Site Optilite Alpha-2-Macroglobulin Kit
TW: 邦迪斯歐普羅Alpha-2-巨球蛋白分析套組
Taiwan·Risk Class 2·MD·THE BINDING SITE GROUP LIMITED·Registered Mar 05, 2019 – Mar 05, 2024ExpiredRegistration details
- Analysis ID
- 2bfc8682e663b562aec76ead466b2575
- License Form
- Ministry of Health Medical Device Import No. 032196
- Customs Code
- DHA05603219601
Company information
- Manufacturer
- THE BINDING SITE GROUP LIMITED
- Manufacturer Country
- United Kingdom
- Authorized Representative
- EVERLIGHT BIOTECH(TAIWAN) CO., LTD.
Product details
- Intended Use
- This product is used with the Binding Site Plite Analyzer for in vitro quantitative analysis of alpha-2-macroglobulin in human serum, lithium heparin salts or EDTA anticoagulant plasma.
- Product Type (Level 1)
- C Immunology and microbiology devices
- Product Type (Level 2)
- C5620 α-2-macroglobulin immunoassay system
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Mar 05, 2019
- Expiry Date
- Mar 05, 2024
About this record
Access comprehensive regulatory information for The Binding Site Optilite Alpha-2-Macroglobulin Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 2bfc8682e663b562aec76ead466b2575 and manufactured by THE BINDING SITE GROUP LIMITED. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices